This Article Full Text Full Text (PDF) All Versions of this Article: 40/5/604    most recent 01.HYP.0000035856.77718.DAv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dedier, J. Articles by Curhan, G. C. Search for Related Content PubMed PubMed Citation Articles by Dedier, J. Articles by Curhan, G. C. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETAMINOPHEN ACETYLSALICYLIC ACID Medline Plus Health Information High Blood Pressure Pain Relievers Related Collections Other hypertension Epidemiology

(Hypertension. 2002;40:604.)
© 2002 American Heart Association, Inc.

Scientific Contribution

Nonnarcotic Analgesic Use and the Risk of Hypertension in US Women

Julien Dedier; Meir J. Stampfer; Susan E. Hankinson; Walter C. Willett; Frank E. Speizer; Gary C. Curhan

From the Section of General Internal Medicine Research Unit, Department of Medicine, Boston Medical Center (J.D.); Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.); and the Departments of Nutrition (M.J.S., W.C.W.) and Epidemiology (M.J.S., S.E.H., W.C.W., F.E.S., G.C.C.), Harvard School of Public Health, Boston, Mass.

Correspondence to Gary Curhan MD, ScD, Channing Laboratory, 181 Longwood Ave, Boston, MA 02115. E-mail gary.curhan{at}channing.harvard.edu

Acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs (NSAIDs) are widely consumed. Each is theoretically capable of elevating blood pressure by altering prostaglandin homeostasis; however, there is little prospective information on the relation between these agents and physician-diagnosed hypertension. We examined the association between the use of aspirin, acetaminophen, or NSAIDs and incident hypertension in a prospective cohort study of 51 630 women 44 to 69 years of age in 1990 who had no history of hypertension or chronic renal insufficiency. Analgesic use was assessed in 1990 by a mailed questionnaire, and the women were followed for 8 years. The primary outcome was physician-diagnosed hypertension reported on a follow-up biennial questionnaire. During 381 078 person-years of follow-up, 10 579 incident cases of hypertension were identified. Compared with nonusers, women who used aspirin or acetaminophen at least 1 day per month or NSAIDs 5 or more days per month were at a significantly higher risk for development of hypertension. After adjusting for potential confounders, the odds ratios for women in the highest frequency of use category (22 days per month) compared with no use were as follows: aspirin, 1.21 (95% CI, 1.13 to 1.30); acetaminophen, 1.20 (1.08 to 1.33); and NSAIDs, 1.35 (1.25 to 1.46). For each analgesic type, there was a significant trend toward an increased risk of incident hypertension with increasing frequency of use (P<0.001). Given the observed odds ratios, biologic plausibility, and the sizeable population at risk, health professionals should consider potential hypertensive effects of aspirin, acetaminophen, and NSAIDs when counseling their patients about the use of nonnarcotic analgesics.

Key Words: hypertension, essential • drug therapy • blood pressure • risk factors

This article has been cited by other articles:

				J. P. Forman, M. J. Stampfer, and G. C. Curhan Diet and Lifestyle Risk Factors Associated With Incident Hypertension in Women JAMA, July 22, 2009; 302(4): 401 - 411. [Abstract] [Full Text] [PDF]

				V. F. Panoulas, G. S. Metsios, A. V. Pace, H. John, G. J. Treharne, M. J. Banks, and G. D. Kitas Hypertension in rheumatoid arthritis Rheumatology, September 1, 2008; 47(9): 1286 - 1298. [Abstract] [Full Text] [PDF]

				D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Circulation, June 24, 2008; 117(25): e510 - e526. [Abstract] [Full Text] [PDF]

				D. A. Calhoun, D. Jones, S. Textor, D. C. Goff, T. P. Murphy, R. D. Toto, A. White, W. C. Cushman, W. White, D. Sica, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research Hypertension, June 1, 2008; 51(6): 1403 - 1419. [Abstract] [Full Text] [PDF]

				B. Montgomery Does paracetamol cause hypertension? BMJ, May 24, 2008; 336(7654): 1190 - 1191. [Full Text] [PDF]

				F. Wieser, M. Cohen, A. Gaeddert, J. Yu, C. Burks-Wicks, S. L. Berga, and R. N. Taylor Evolution of medical treatment for endometriosis: back to the roots? Hum. Reprod. Update, September 1, 2007; 13(5): 487 - 499. [Abstract] [Full Text] [PDF]

				J. P. Forman, E. B. Rimm, and G. C. Curhan Frequency of Analgesic Use and Risk of Hypertension Among Men Arch Intern Med, February 26, 2007; 167(4): 394 - 399. [Abstract] [Full Text] [PDF]

				W. C. Winkelmayer, M. J. Stampfer, W. C. Willett, and G. C. Curhan Habitual Caffeine Intake and the Risk of Hypertension in Women JAMA, November 9, 2005; 294(18): 2330 - 2335. [Abstract] [Full Text] [PDF]

				T. Kurth, C. H. Hennekens, T. Sturmer, H. D. Sesso, R. J. Glynn, J. E. Buring, and J. M. Gaziano Analgesic Use and Risk of Subsequent Hypertension in Apparently Healthy Men Arch Intern Med, September 12, 2005; 165(16): 1903 - 1909. [Abstract] [Full Text] [PDF]

				T. Sturmer, S. Schneeweiss, J. Avorn, and R. J. Glynn Adjusting Effect Estimates for Unmeasured Confounding with Validation Data using Propensity Score Calibration Am. J. Epidemiol., August 1, 2005; 162(3): 279 - 289. [Abstract] [Full Text] [PDF]

				R. A. Khalil Sex Hormones as Potential Modulators of Vascular Function in Hypertension Hypertension, August 1, 2005; 46(2): 249 - 254. [Abstract] [Full Text] [PDF]

				T. Sturmer, S. Schneeweiss, M. A. Brookhart, K. J. Rothman, J. Avorn, and R. J. Glynn Analytic Strategies to Adjust Confounding using Exposure Propensity Scores and Disease Risk Scores: Nonsteroidal Antiinflammatory Drugs and Short-term Mortality in the Elderly Am. J. Epidemiol., May 1, 2005; 161(9): 891 - 898. [Abstract] [Full Text] [PDF]

				J. P. Forman, E. B. Rimm, M. J. Stampfer, and G. C. Curhan Folate Intake and the Risk of Incident Hypertension Among US Women JAMA, January 19, 2005; 293(3): 320 - 329. [Abstract] [Full Text] [PDF]

				W. Dai and R. A. Kloner Effects of Acetaminophen on Myocardial Infarct Size in Rats Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2003; 8(4): 277 - 284. [Abstract] [PDF]

				G. C. Curhan and M. J. Stampfer NSAIDs and Hypertension--Reply Arch Intern Med, May 12, 2003; 163(9): 1115 - 1116. [Full Text] [PDF]

				Analgesic Use and Hypertension Risk in Women Journal Watch Cardiology, January 31, 2003; 2003(131): 5 - 5. [Full Text]

				B. M. Egan Nonnarcotic Analgesic Use and the Risk of Hypertension in US Women Hypertension, November 1, 2002; 40(5): 601 - 603. [Full Text] [PDF]